No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
HRTX Heron Therapeutics
- 1.580
- +0.050+3.27%
Close Dec 20 16:00 ET
- 1.540
- -0.040-2.53%
Post 20:01 ET
240.31MMarket Cap-9.88P/E (TTM)
1.620High1.460Low2.57MVolume1.480Open1.530Pre Close4.05MTurnover2.24%Turnover RatioLossP/E (Static)152.09MShares3.93052wk High-6.01P/B181.70MFloat Cap1.04052wk Low--Dividend TTM115.00MShs Float830.000Historical High--Div YieldTTM10.46%Amplitude0.500Historical Low1.574Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Needham Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Maintains Target Price $4
Analysts Offer Insights on Healthcare Companies: Biohaven Ltd. (BHVN), Arrowhead Pharmaceuticals (ARWR) and Heron Therapeutics (HRTX)
Heron Therapeutics Secures Revenue Stream With Court Ruling, Analyst Recommends Buy
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Sector Update: Health Care Stocks Steady Pre-Bell Wednesday
Traders Await Powell Comments as US Equity Futures Post Premarket Gains
Heat List
US
Overall
Symbol
Price
% Chg
No Data